A detailed history of Plante Moran Financial Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 70 shares of OGN stock, worth $1,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 134 47.76%
Holding current value
$1,069
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

SELL
$14.44 - $18.83 $924 - $1,205
-64 Reduced 47.76%
70 $1,000
Q3 2024

Oct 30, 2024

SELL
$18.65 - $23.03 $20,570 - $25,402
-1,103 Reduced 89.17%
134 $2,000
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $663 - $834
-38 Reduced 2.98%
1,237 $25,000
Q4 2023

Feb 05, 2024

SELL
$10.95 - $17.32 $689 - $1,091
-63 Reduced 4.71%
1,275 $18,000
Q3 2023

Nov 07, 2023

SELL
$16.59 - $23.77 $398 - $570
-24 Reduced 1.76%
1,338 $23,000
Q2 2023

Aug 07, 2023

SELL
$19.27 - $24.63 $19 - $24
-1 Reduced 0.07%
1,362 $28,000
Q1 2023

May 08, 2023

SELL
$21.42 - $32.08 $5,376 - $8,052
-251 Reduced 15.55%
1,363 $32,000
Q4 2022

Feb 09, 2023

BUY
$23.31 - $28.61 $26,759 - $32,844
1,148 Added 246.35%
1,614 $45,000
Q3 2022

Nov 02, 2022

SELL
$23.4 - $34.25 $1,240 - $1,815
-53 Reduced 10.21%
466 $11,000
Q2 2022

Aug 02, 2022

BUY
$31.66 - $38.9 $316 - $389
10 Added 1.96%
519 $18,000
Q1 2022

May 06, 2022

SELL
$30.45 - $39.36 $1,431 - $1,849
-47 Reduced 8.45%
509 $18,000
Q4 2021

Feb 09, 2022

SELL
$28.67 - $37.13 $4,472 - $5,792
-156 Reduced 21.91%
556 $17,000
Q3 2021

Nov 08, 2021

SELL
$28.63 - $35.64 $31,550 - $39,275
-1,102 Reduced 60.75%
712 $23,000
Q2 2021

Aug 10, 2021

BUY
$28.45 - $38.0 $51,608 - $68,932
1,814 New
1,814 $55,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.